started · updated
Boston Medical Sciences raises 5.55 billion yen for AI colon cancer screening
Boston Medical Sciences, a startup founded by physicians from Harvard Medical School and Massachusetts General Hospital, has raised 5.55 billion yen in a Series B funding round. The investment was co-led by Nomura Sparks Investment, Global Brain, and Beyond Next Ventures, with participation from Aflac Ventures Japan, Meiji Yasuda Life, and Japan Airlines.
The company is developing AIM4CRC, a “laxative-free virtual endoscopy” technology. This medical AI system aims to reduce the physical and psychological burden of colon cancer screenings by using AI to virtually clean the intestines from CT images and assist in detecting polyps.
The technology has completed clinical trials in Japan and has received Breakthrough Device Designation from the US FDA. Funds from this round will be used for R&D in AI and medical image analysis, building clinical evidence, navigating regulatory processes in Japan and the US, and expanding international partnerships.
Entities
Boston Medical Sciences · Global Brain · Harvard Medical School · Massachusetts General Hospital · Nomura Sparks Investment